Keystone Symposium June 18th, 2019 – Keystone, CO, USA Learn more Dieter Willbold will present PRI-002 at the Keystone Symposium “Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2) in Keystone, CO, USA. News & Events: Priavoid closes financing round12. Februar 2021 Sprunginnovationsprojekt geht neue Wege in der Alzheimer-Therapie11. Februar 2021 Alzheimer´s Research: Important Milestone for PRI-0024. Februar 2021 Nobel Prize winner Stanley Prusiner joins Priavoid’s supervisory board9. Dezember 2020 New CEO of Priavoid2. September 2020 Priavoid Headquarters at LSC Düsseldorf6. März 2020 Seed Investment6. Mai 2019 Prof. Willbold´s interview with PharmaVentures23. Januar 2018 Clinical trial with PRI-00231. Mai 2017